Sensodyne maker Haleon reports organic revenue growth sligtly below estimates
29/04/2026 07:08
April 29 (Reuters) - British consumer healthcare group Haleon HLN.L on Wednesday reported first quarter revenue growth slightly below analyst expectations, as weakness in other international markets offset growth in North America. The Sensodyne maker reported organic revenue growth of 2.2% for the three months through March, compared to analysts' expectations of 2.3%, according to the company-compiled consensus. (Reporting by Raechel Thankam Job in Bengaluru; Editing by Ronojoy Mazumdar) ((RaechelThankam.Job@thomsonreuters.com;))